On the heels of Microchips Biotech's $35 million partnership with Teva to apply the company's electronic drug delivery implant for administration over months to years toward at least one disease area, the company announced that Cheryl Blanchard, the former chief scientific officer of Zimmer, will become its new CEO.
Microchips Biotech says it's ready to send its delivery technology out into the world, this week announcing it has completed development and clinical demonstration of the drug-delivering implant.
A new contraceptive implant developed by Lexington, MA-based MicroCHIPS could give women remote-controlled access to their hormone administration, offering up to 16 years of specifically dosed delivery and thus more authority over their birth control regimens.
After years of writing about companies with technology that stemmed from the mind of legendary MIT professor Robert Langer, I finally got to chat with him on the phone.
MicroCHIPS heavily promoted some long-awaited good news this week about its wireless, implantable drug delivery microchip. A small human trial proved that it can work in people, and the patients were...
Drug delivery device developer MicroCHIPS, based in Waltham, MA, has been granted a U.S. Patent that, the company says, "provides broad coverage for the design and fabrication of reservoir-based
MicroCHIPS of Bedford, MA, is initiating its first test for its implantable pump to deliver human parathyroid hormone marketed by Eli Lilly as Forteo, a drug that can actually rebuild bone in women